Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Primer on MSCs in clinical trials

. In this podcast titled “Opportunities and Challenges in Developing Innovative Stem Cell Therapies,” Dr. Armand Keating focuses specifically on the commercialization of mesenchymal stem cells (stromal cells). He has established the largest stem cell transplant...

Right Turn: Biting into some incredible art

Developmental biologists among you may be aware that voting in the Node’s image competition wrapped this week. Five wonderful images were in the running for the cover on a future issue of Development – and bragging rights, of course. I discovered the...

Right Turn: Research at the bleeding edge. Literally.

How many university students can say they invented a product that people around the world will want to use? For that matter, how many people have ever invented a product that made it to the market?! Joe Landolina is CEO and Co-Founder of Suneris, Inc. and a student at...

Social media and stem cells: Time to start tweeting

Why should stem cell researchers use Twitter? Powerful news aggregator/information filter Able to engage/converse with other attendees at conferences & meetings Increase traffic, discussion and citations of your papers Create professional networks and...

Right Turn: stem cell comic relief

Last week we launched a new feature — Right Turn — to showcase the “lighter” side of regenerative medicine. Every Friday, we will be bringing you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions...

Lego® and biomaterials: the building blocks of life

When I was a child, I would sit on my living room floor playing with my Lego set for hours on end. I recall building police cars, giant spaceships and all kinds of other amazing structures. My weekend mornings always began the same way: I would dump my box of Legos...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!